 |
인쇄하기
취소
|
KFDA requires additional warning for co-administration of 30 medicines
The concomitant therapy of 30 drugs carries the risks of side effects, and from now on, the Korea Food and Drug Administration (KFDA) says those risks have to be spelled out in detail on the product labels.
The drug agency issued an additional rule that requires manufacturers of 30 pharmaceutical manufacturers to revise their labeling to include warnings about potential safety risks associat...
The drug agency issued an additional rule that requires manufacturers of 30 pharmaceutical manufacturers to revise their labeling to include warnings about potential safety risks associat...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.